Meteora Capital’s Cidara Therapeutics CDTX Stock Holding History

Meteora Capital’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,801	Closed	-$840K	–	388
2025 Q4	$840K	Buy	+3,801	New	+$614K	0.07%	136

Meteora Capital's CDTX Position: Q1 2026 in Review

Meteora Capital sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 3,801 shares — an estimated $840K sold.

Meteora Capital first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $840K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Meteora Capital reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Meteora Capital sold 3,801 Cidara Therapeutics shares in Q1 2026, an estimated $840K.
Meteora Capital first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Meteora Capital's Cidara Therapeutics position peaked at $840K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Meteora Capital's 13F filing for Q1 2026, filed 15 May 2026.